Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Epigenomics AG

EPGNF
Current price
0.79 USD 0 USD (0.00%)
Last closed 0.79 USD
ISIN unknown
Sector Healthcare
Industry Diagnostics & Research
Exchange PINK
Capitalization 691 368 USD
Yield for 12 month -75.69 %
1Y
3Y
5Y
10Y
15Y
EPGNF
21.11.2021 - 28.11.2021

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. The company was founded in 1998 and is headquartered in Berlin, Germany. Address: Geneststrasse 5, Berlin, Germany, 10829

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.59 USD

P/E ratio

Dividend Yield

Current Year

+339 227 USD

Last Year

+485 000 USD

Current Quarter

+68 114 USD

Last Quarter

+68 114 USD

Current Year

+282 315 USD

Last Year

+365 000 USD

Current Quarter

+61 158 USD

Last Quarter

+61 158 USD

Key Figures EPGNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 163 961 USD
Operating Margin TTM -214.1 %
PE Ratio
Return On Assets TTM 31.99 %
PEG Ratio
Return On Equity TTM -175.41 %
Wall Street Target Price 8.59 USD
Revenue TTM 136 227 USD
Book Value -9.53 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -44.3 %
Dividend Yield
Gross Profit TTM 6 067 000 USD
Earnings per share -21.73 USD
Diluted Eps TTM -21.73 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin 2176.13 %

Dividend Analytics EPGNF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EPGNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio
Last Split Date 20.12.2023
Dividend Date

Stock Valuation EPGNF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.4487
Price Sales TTM 5.0751
Enterprise Value EBITDA 0.1315
Price Book MRQ 0.3257

Financials EPGNF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EPGNF

For 52 weeks

0.5 USD 2.5 USD
50 Day MA 0.79 USD
Shares Short Prior Month
200 Day MA 0.7 USD
Short Ratio
Shares Short
Short Percent